Hormone Therapy Timing & Heart Risk
study3_post06  |  image: study3_post06_clinical.png
------------------------------------------------------------------------

ON THE IMAGE
Does your heart risk get assessed with menopause in mind?

CAPTION
A gap this review names directly.

Widely used cardiovascular risk calculators weren't designed around menopause. They don't incorporate age at menopause, whether it was natural or surgical, symptom severity, or hormone therapy formulation and route — and they may underestimate risk in younger postmenopausal women.

The authors argue for a menopause-specific risk tool. Until one exists, the clinical conversation carries that weight.

Questions about what this means for you? Call [Practice Name] at [Phone] or book at [Booking Link].

Educational content, not medical advice — individual results and risks vary.

HASHTAGS
#menopause #womenshealth #hearthealth #hormonetherapy #midlifewomen

SUPPORTING EVIDENCE
Knowledge gaps section: QRISK3 and ASCVD Pooled Cohort Equations do not specifically account for menopause-related variables.
